Growth of hepatitis A virus in a mouse liver cell line

Journal of Virology

Volumn 79, Issue 5, 2005, Pages 2950-2955

  Feigelstock, Dino A ^a   Thompson, Peter ^a   Kaplan, Gerardo G ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GROWTH FACTOR; VIRUS RNA;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL CLONE; CELL CULTURE; CELL IMMORTALIZATION; CELL TRANSFORMATION; CONTROLLED STUDY; CULTURE OPTIMIZATION; GENETIC TRANSFECTION; GROWTH STIMULATION; HEPATITIS A VIRUS; INFECTION SENSITIVITY; LIVER CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIMATE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIROGENESIS; VIRUS CAPSID; VIRUS PARTICLE; VIRUS REPLICATION;

ANIMALS; BASE SEQUENCE; CAPSID PROTEINS; CELL CULTURE TECHNIQUES; CELL LINE; DNA, VIRAL; HEPATITIS A VIRUS; HEPATOCYTES; MICE; MUTATION; RNA, VIRAL; TRANSFECTION; VARIATION (GENETICS); VIRUS REPLICATION;

ANIMALIA; HEPATITIS A VIRUS; MIRIDAE; MURINAE; PRIMATES; RNA VIRUSES;

EID: 13944268227     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.5.2950-2955.2005     Document Type: Article

References (38)

1. Almog, R., M. Low, D. Cohen, G. Robin, S. Ashkenazl, H. Bercovier, M. Gdalevich, Y. Samuels, I. Ashkenazi, J. Shemer, A. Eldad, and M. S. Green. 1999. Prevalence of anti-hepatitis A antibodies, hepatitis B viral markers, and anti-hepatitis C antibodies among immigrants from the former USSR who arrived in Israel during 1990-1991. Infection 27:212-217.
2. Amicone, L., F. M. Spagnoli, G. Spath, S. Giordano, C. Tommasini, S. Bernardini, V. De Luca, C. Della Rocca, M. C. Weiss, P. M. Comoglio, and M. Tripodi. 1997. Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytes. EMBO J. 16:495-503.
3. An, G., G. Luo, and R. Wu. 1994. Expression of MUC2 gene is down-regulated by vitamin A at the transcriptional level in vitro in tracheobronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 10:546-551.
4. Antoine, B., F. Levrat, V. Vallet, T. Berbar, N. Cartier, N. Dubois, P. Briand, and A. Kahn. 1992. Gene expression in hepatocyte-like lines established by targeted carcinogenesis in transgenic mice. Exp. Cell Res. 200:175-185.
5. Arankalle, V. A., S. A. Tsarev, M. S. Chadha, D. W. Alling, S. U. Emerson, K. Banerjee, and R. H. Purcell. 1995. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J. Infect. Dis. 171:447-450.
6. Cohen, J. I., B. Rosenblum, J. R. Ticehurst, R. J. Daemer, S. M. Feinstone, and R. H. Purcell. 1987. Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus. Proc. Natl. Acad. Sci. USA 84:2497-2501.
7. Daemer, R. J., S. M. Feinstone, I. D. Gust, and R. H. Purcell. 1981. Propagation of human hepatitis A virus in African green monkey kidney cell culture: primary isolation and serial passage. Infect. Immun. 32:388-393.
8. Dienstag, J. L., S. M. Feinstone, A. Z. Kapikian, and R. H. Purcell. 1975. Faecal shedding of hepatitis-A antigen. Lancet i:765-767.
9. Dotzauer, A., S. M. Feinstone, and G. Kaplan. 1994. Susceptibility of non-primate cell lines to hepatitis A virus infection. J. Virol. 68:6064-6068.
10. Emerson, S. U., Y. K. Huang, and R. H. Purcell. 1993. 2B and 2C mutations are essential but mutations throughout the genome of HAV contribute to adaptation to cell culture. Virology 194:475-480.
11. Feigelstock, D., P. Thompson, P. Mattoo, Y. Zhang, and G. G. Kaplan. 1998. The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor. J. Virol. 72:6621-6628.
12. Funkhouser, A. W., R. H. Purcell, E. D'Hondt, and S. U. Emerson. 1994. Attenuated hepatitis A virus: genetic determinants of adaptation to growth in MRC-5 cells. J. Virol. 68:148-157.
13. Hadler, S. C., and L. McFarland. 1986. Hepatitis in day care centers: epidemiology and prevention. Rev. Infect. Dis. 8:548-557.
14. Hollinger, F. B., and S. U. Emerson. 2001. Hepatitis A virus, p. 799-840. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed., vol. 1. Lippincott Williams & Wilkins, Philadelphia, Pa.
15. Kiyohara, T., T. Satoh, H. Yamamoto, A. Totsuka, and Y. Moritsugu. 1997. The latest seroepidemiological pattern of hepatitis A in Japan. Jpn. J. Med. Sci. Biol. 50:123-131.
16. Lednar, W. M., S. M. Lemon, J. W. Kirkpatrick, R. R. Redfield, M. L. Fields, and P. W. Kelley. 1985. Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am. J. Epidemiol. 122:226-233.
17. LeDuc, J. W., S. M. Lemon, C. M. Keenan, R. R. Graham, R. H. Marchwicki, and L. N. Binn. 1983. Experimental infection of the New World owl monkey (Aotus trivirgatus) with hepatitis A virus. Infect. Immun. 40:766-772.
18. Li, J., and N. J. Holbrook. 2003. Common mechanisms for declines in oxidative stress tolerance and proliferation with aging. Free Radic. Biol. Med. 35:292-299.
19. Lu, J., G. Dveksler, and G. G. Kaplan. 2004. Rescue of hepatitis A virus from cDNA-transfected but not virion RNA-transfected mouse Ltk- cells. Arch. Virol. 149:759-772.
20. Luo, M., M. G. Rossmann, and A. C. Palmenberg. 1988. Prediction of three-dimensional models for foot-and-mouth disease virus and hepatitis A virus. Virology 166:503-514.
21. Mathiesen, L. R., F. Hardt, O. Dietrichson, R. H. Purcell, D. Wong, P. Skinhoj, J. O. Nielsen, H. Zoffmann, and K. Iversen. 1980. The role of acute hepatitis type A, B, and non-A non-B in the development of chronic active liver disease. Scand. J. Gastroenterol. 15:49-54.
22. Matricardi, P. M., F. Rosmini, L. Ferrigno, R. Nisini, M. Rapicetta, P. Chionne, T. Stroffolini, P. Pasquini, and R. D'Amelio. 1997. Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ 314:999-1003.
23. Matricardi, P. M., F. Rosmini, V. Panetta, L. Ferrigno, and S. Bonini. 2002. Hay fever and asthma in relation to markers of infection in the United States. J. Allergy Clin. Immunol. 110:381-387.
24. McIntire, J. J., S. E. Umetsu, O. Akbari, M. Potter, V. K. Kuchroo, G. S. Barsh, G. J. Freeman, D. T. Umetsu, and R. H. DeKruyff. 2001. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat. Immunol. 2:1109-1116.
25. McIntire, J. J., S. E. Umetsu, C. Macaubas, E. G. Hoyte, C. Cinnioglu, L. L. Cavalli-Sforza, G. S. Barsh, J. F. Hallmayer, P. A. Underbill, N. J. Risch, G. J. Freeman, R. H. DeKruyff, and D. T. Umetsu. 2003. Immunology: hepatitis A virus link to atopic disease. Nature 425:576.
26. Nainan, O. V., M. A. Brinton, and H. S. Margolis. 1992. Identification of amino acids located in the antibody binding sites of human hepatitis A virus. Virology 191:984-987.
27. Palmer, H. J., C. T. Tuzon, and K. E. Paulson. 1999. Age-dependent decline in mitogenic stimulation of hepatocytes. Reduced association between She and the epidermal growth factor receptor is coupled to decreased activation of Raf and extracellular signal-regulated kinases. J. Biol. Chem. 274:11424-11430.
28. Provost, P. J., and M. R. Hilleman. 1979. Propagation of human hepatitis A virus in cell culture in vitro. Proc. Soc. Exp. Biol. Med. 160:213-221.
29. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty per cent end points. Am. J. Hyg. 27:493-497.
30. Robertson, B. H., V. K. Brown, B. P. Holloway, B. Khanna, and E. Chan. 1989. Structure of the hepatitis A virion: identification of potential surface-exposed regions. Arch. Virol. 104:117-128.
31. Roth, G. S. 1995. Changes in tissue responsiveness to hormones and neurotransmitters during aging. Exp. Gerontol. 30:361-368.
32. Silberstein, E., G. Dveksler, and G. G. Kaplan. 2001. Neutralization of hepatitis A virus (HAV) by an immunoadhesin containing the cysteine-rich region of HAV cellular receptor-1. J. Virol. 75:717-725.
33. Silberstein, E., L. Xing, W. van de Beek, J. Lu, H. Cheng, and G. G. Kaplan. 2003. Alteration of hepatitis A virus (HAV) particles by a soluble form of HAV cellular receptor 1 containing the immunoglobulin- and mucin-like regions. J. Virol. 77:8765-8774.
34. Spagnoli, F. M., L. Amicone, M. Tripodi, and M. C. Weiss. 1998. Identification of a bipotential precursor cell in hepatic cell lines derived from transgenic mice expressing cyto-Met in the liver. J. Cell Biol. 143:1101-1112.
35. Takeda, Y., M. Ashida, and C. Hamada. 1996. Growth of hepatitis A virus in murine cells. Acta Virol. 40:201-208.
36. Thompson, P., J. Lu, and G. G. Kaplan. 1998. The Cys-rich region of hepatitis A virus cellular receptor 1 is required for binding of hepatitis A virus and protective monoclonal antibody 190/4. J. Virol. 72:3751-3761.
37. Umetsu, D. T., J. J. McIntire, O. Akbari, C. Macaubas, and R. H. DeKruyff. 2002. Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 3:715-720.
38. Zhang, Y., and G. G. Kaplan. 1998. Characterization of replication-competent hepatitis A virus constructs containing insertions at the N terminus of the polyprotein. J. Virol. 72:349-357.